|
|
|
41
|
67351
|
ULTRAVIST 370 INJ (BSP) IOPROMIDE (BQ)
|
IOPROMIDE
|
ULTRAVIST
|
100ML
|
BQ
|
112.59
|
112.593
|
BOTT
|
7
|
BOTT
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
3668
|
ROENTGENOGRAPHY
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
42
|
67351
|
ULTRAVIST 370 INJ (BSP) IOPROMIDE
|
IOPROMIDE
|
ULTRAVIST
|
100ML
|
BQ
|
112.59
|
112.59
|
BOTT
|
7
|
BOTT
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
3668
|
ROENTGENOGRAPHY
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
40
|
67358
|
ULTRAVIST 370 INJ (BSP/COL) IOPROMIDE
|
IOPROMIDE
|
ULTRAVIST
|
100ML
|
BQ
|
103.05
|
103.05
|
INJECTION
|
0
|
BOTT
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
DIAGNOSTIC AGENTS
|
|
|
|
|
41
|
67358
|
ULTRAVIST 370 INJ (BSP) IOPROMIDE (BQ)
|
IOPROMIDE
|
ULTRAVIST
|
100ML
|
BQ
|
112.59
|
112.593
|
BOTT
|
7
|
BOTT
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
3668
|
ROENTGENOGRAPHY
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
42
|
67358
|
ULTRAVIST 370 INJ (BSP) IOPROMIDE
|
IOPROMIDE
|
ULTRAVIST
|
100ML
|
BQ
|
102.45
|
102.45
|
BOTT
|
7
|
BOTT
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
3668
|
ROENTGENOGRAPHY
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ROENTGENOGRAPHY
|
|
|
|
|
40
|
6735E
|
XULVARIO 350MG/ML INJ (UNI/AHI) IOHEXOL
|
IOHEXOL
|
XULVARIO
|
100ML
|
BQ
|
55.62
|
55.62
|
INJECTION
|
0
|
BOTT
|
UNI
|
UNIQUE PHARMACEUTICAL LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
3668
|
ROENTGENOGRAPHY
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
DIAGNOSTIC AGENTS
|
|
|
|
|
40
|
6781R
|
ETOPOSIDE 20MG/ML INJ (INP/AHI)
|
ETOPOSIDE
|
ETOPOSIDE
|
5ML VIAL
|
BQ
|
17.21
|
17.21
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
6781W
|
ZUVITOP 20MG/ML INJ (ZUV) ETOPOSIDE
|
ETOPOSIDE
|
ZUVITOP
|
5ML VIAL
|
BQ
|
12.29
|
12.2868
|
VIAL
|
40
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
6781Y
|
POSID 20MG/ML INJ (CAD) ETOPOSIDE
|
ETOPOSIDE
|
POSID
|
5ML VIAL
|
BQ
|
8.75
|
8.75
|
VIAL
|
40
|
VIAL
|
CAD
|
CADILA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
67827
|
ZUVITOP 50MG CAP (ZUV) ETOPOSIDE
|
ETOPOSIDE
|
ZUVITOP
|
20'S
|
BQ
|
32.18
|
1.6092
|
CAP
|
10
|
BOTT
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2024-05-17
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
41
|
67828
|
ZUVITOP 50MG TAB (ZUV) ETOPOSIDE
|
ETOPOSIDE
|
ZUVITOP
|
8'S
|
BQ
|
26.34
|
3.2925
|
TAB
|
10
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-05
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
2024-04-05
|
|
|
|
42
|
67828
|
ZUVITOP 50MG TAB (ZUV) ETOPOSIDE
|
ETOPOSIDE
|
ZUVITOP
|
8'S
|
BQ
|
24.03
|
3.00
|
TAB
|
0
|
BLIS
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
67911
|
PHARIXIA 0.15% RINSE (PMS/COL) BENZYDAMINE
|
BENZYDAMINE
|
PHARIXIA
|
250ML
|
BQ
|
8.83
|
8.83
|
ORAL RINSE
|
0
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
67911
|
PHARIXIA 0.15% RINSE (PMS) BENZYDAMINE
|
BENZYDAMINE
|
PHARIXIA
|
250ML
|
BQ
|
14
|
13.9994
|
BOTT
|
0
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
COLLINS LTD
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
0
|
MOUTH WASHES AND GARGLES
|
|
|
|
|
42
|
67911
|
PMS-BENZYDAMINE 0.15% RINSE (PMS)
|
BENZYDAMINE
|
PMS-BENZYDAMINE
|
250ML
|
B
|
9.51
|
9.51
|
BOTT
|
0
|
BOTT
|
PMS
|
PHARMASCIENCE
|
COL
|
AVENTA BARBADOS
|
|
5228
|
MOUTH WASHES AND GARGLES
|
2026-04-01
|
2028-03-31
|
|
TOPICAL
|
0
|
MOUTH WASHES AND GARGLES
|
|
|
|
|
40
|
6801F
|
ZEVERT 8MG TAB (INP/AHI) BETAHISTINE
|
BETAHISTINE
|
ZEVERT
|
120'S
|
A
|
8.32
|
0.07
|
TABLET
|
90
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2412
|
VASODILATING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
6801G
|
BETASERC 16MG TAB (ABB/PHA) BETAHISTINE
|
BETAHISTINE
|
BETASERC
|
20'S
|
C
|
12.56
|
0.63
|
TABLET
|
0
|
TAB
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2412
|
VASODILATING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
6801G
|
BETASERC 16MG TAB (ABB/PHA) BETAHISTINE (C)
|
BETAHISTINE
|
BETASERC
|
20'S
|
C
|
12.56
|
0.628
|
TABLET IMMED
|
|
|
ABB
|
ABBOTT
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2412
|
VASODILATING AGENTS
|
2022-04-01
|
2023-03-31
|
Delete from contract
|
Oral
|
0
|
VASODILATING AGENTS
|
2023-03-02
|
|
|
|
41
|
6801H
|
ZEVERT 16MG TAB (INP) BETAHISTINE
|
BETAHISTINE
|
ZEVERT
|
5X10
|
A
|
7.88
|
0.1577
|
TAB
|
90
|
BOX
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2412
|
VASODILATING AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
VASODILATING AGENTS
|
|
|
|
|
42
|
6801M
|
VERTILINE 16MG TAB (JLP) BETAHISTINE
|
BETAHISTINE
|
VERTILINE
|
10X10
|
A
|
6.80
|
0.07
|
TAB
|
90
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2412
|
VASODILATING AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
6
|
VASODILATING AGENTS
|
|
